A year of growth and opportunity
Updated: Feb 15
A letter from our founders
At the start of 2022, Lynx.MD could only imagine the amazing growth and partnerships we would experience this year. As founders, our goal has always been to break down the barriers to sharing healthcare information. We knew this would be the greatest challenge but would result in improvements in patients care. The use of data has revolutionized other industries, but healthcare has continued to be left behind. We knew that building a secure platform would bring together healthcare organizations from across the ecosystem to collaborate using real-world clinical data that would influence the development of new therapeutics and create value for our partners. Unlock this value close to home first was the first step. Our vision was realized this year when we announced our partnerships with Clalit and the Ministry of Health, releasing the bottleneck for accessing data generated by millions of patient encounters.
Through our partnerships with companies like Gastro Health, ENT & Allergy Associates, ENT Partners and Albany ENT, we have created specialty-focused clinical data repositories in gastroenterology, allergy and otolaryngology spaces. Collectively this represents data from hundreds of millions of patient encounters—effectively telling the stories of these patients, their disease progression, and the management of their care. Bringing together data silos and being able to follow patients across their journey with multi-modal data of medical records, PACS imaging, and other data systems brings new opportunities to help healthcare realize the potential locked away in the data. Organizations need visibility through analytics into the true cost of delivering care to achieve operational goals while meeting the needs of their community. Researchers in all related industries need secure access to anonymized real-world patient data to bring diagnostic technology, and novel therapeutics to market faster and safely. This is an imperative that we all witnessed during the pandemic. Our partners have been helping us evolve use cases for our platform to meet the evolving needs of the industry as it phase-changes with the completion of the crisis.
One area where our partners have provided deep insights is into the new regulatory and policy directives that are making collaboration with data harder, yet more imperative. Changes in EU regulations that require medical devices be proven on EU citizens, the NIH Data Management and Sharing (DMS) policy, and an industry awakening to the damage created by population demographic bias in research all point to equitable, secure sharing of real-world clinical data. Collaboration is no longer an option – it is now a business necessity. Platforms, like Lynx, are one way for healthcare providers to maintain the governance of data while collaborating in a secure, private manner. This challenges historical approaches for data sharing and where data had to be transported. Today, data holders can retain sensitive patient data and only allow permissioned users to access the data in compliance with new and existing regulations.
Lynx would not be able to meet the high expectations of our partners if we did not continue to invest in our people. With the addition of new team members across the company, we tripled our staff. Our presence in the US, with new customers and employees also grew. We welcomed new executives to our leadership team. Dr. Alyssa Abo, a Lynx champion from Children’s National Hospital, joined our team as Vice President of Medical Affairs and Strategic Partnerships. Alyssa brings the client perspective to our team and to every client engagement. Jody Bare joined Lynx as Vice President of Sales. Jody is leading our US growth strategy with a focus to bring new health systems into the ecosystem. And, Eyal Herman most recently joined us as Vice President of Product. With the platform growing so quickly, it was time to bring in a strong product leader with experience building teams and directing the development of new solutions in cloud, AI, data, and healthcare.
As we close out 2022 we want to recognize all of our team members that worked countless hours across geographies to deliver a truly powerful platform that is exceeding our customer's expectations. And, we thank our partners in healthcare and in business for opening our minds to new ideas and the potential created through the Lynx.MD platform.
We look forward to working with you in 2023.
Omer Dror Rob Eisdorfer Ofir Farchy
CEO & Co-founder CMO & Co-founder CTO & Co-founder